Company
Iris
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
1
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
Recall records
8
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Iris, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Iris.
Latest FDA decisions
K230380 · Decided Aug 3, 2023 · 171 days after receipt
Device type: Mask, Surgical (FXX) · General & Plastic Surgery
K171083 · Decided May 12, 2017 · 31 days after receipt
Device type: Method, Enzymatic, Glucose (Urinary, Non-Quantitative) (JIL) · Laboratory Medicine & Pathology
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT01977521 · 62 participants (planned) · Start Apr 2014 · Primary completion Feb 2018
Device: Eldith DC Stimulator stimulation; Eldith DC Stimulator sham stimulation · For: Psychotic Disorders; Mood Disorders; Personality Disorders and 2 more
Sites: Utrecht, Netherlands
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2441-2015 · Started Jul 15, 2015 · Posted by FDA Aug 21, 2015
Reason given: Iris International is recalling the iChemVELOCITY systems because they do not maintain the on-board strip stability claim of 5 days at 18-28 degrees celsius at 20-80% relative humidity (RH) as stated in the iChemVELOCITY product labeling.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Automated Urinalysis System (KQO)
Z-0857-2015 · Started Dec 3, 2014 · Posted by FDA Dec 23, 2014
Reason given: Iris International is recalling the RTH8 Rotor used in the StatSpin Express 4 Horizontal Centrifuge because the RTH8 rotor may develop cracks with use over time.
Cause as FDA categorized it: Component design/selection · Device type: Centrifuges (Micro, Ultra, Refrigerated) For Clinical Use (JQC)
Z-1328-2013 · Started Sep 18, 2012 · Posted by FDA May 15, 2013
Reason given: The firm initiated this recall because complaints from customers reported that the recovery compared to assigned assay values is significantly below specification. This results in the instrument not passing controls and the customer not being able to run patient samples.
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Urinalysis Controls (Assayed And Unassayed) (JJW)
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.